MEG3 and neoplasm: The differential expression of MEG3 and linc-ROR between colorectal cancer cells and HeLa cells indicates that the bidirectional CEA promoter exerts a specific regulatory effect on gene expression in colon cancer, establishing it as a promising tumor-specific promoter [77].